Utah Medical Products Shares Cross Above 200-Day Average

Analysts Weigh in on Whether It's Time to Sell the Stock

Mar. 17, 2026 at 7:33am

Got story updates? Submit your updates here. ›

Shares of Utah Medical Products, Inc. (NASDAQ:UTMD) have crossed above their 200-day moving average, prompting questions about whether it's time for investors to sell the stock. The medical device company, headquartered in Midvale, Utah, has seen its stock price rise to $64.00 as of the latest trading session.

Why it matters

Crossing above the 200-day moving average is often seen as a bullish signal, indicating the stock may be entering a new upward trend. However, some analysts are cautioning that it may be time for investors to consider selling their positions in Utah Medical Products.

The details

Utah Medical Products is a designer, manufacturer, and marketer of single-use medical devices, with a focus on respiratory therapy and patient monitoring applications. The company's core product portfolio includes tracheostomy tubes, endotracheal tube holders, disposable catheters, and sensors for measuring end-tidal carbon dioxide. According to the latest data, the company has a market cap of $204.80 million and a price-to-earnings ratio of 18.39.

  • Utah Medical Products' stock price crossed above its 200-day moving average of $60.44 during trading on Monday.
  • The company last reported quarterly earnings on January 29, 2026.

The players

Utah Medical Products, Inc.

A designer, manufacturer, and marketer of single-use medical devices, with a focus on respiratory therapy and patient monitoring applications.

Weiss Ratings

A research firm that recently upgraded its rating on Utah Medical Products from "sell (d+)" to "hold (c-)".

Got photos? Submit your photos here. ›

What they’re saying

“We must not let individuals continue to damage private property in San Francisco.”

— Robert Jenkins, San Francisco resident

The takeaway

Crossing above the 200-day moving average is often seen as a bullish signal, but some analysts are cautioning that it may be time for investors to consider selling their positions in Utah Medical Products. The company's core business and financial performance will be key factors to monitor going forward.